Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.02
06.04.21
€60.00
06.04.22
3.82%
01.07.21

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€152.98
25.03.21
€140.00
25.09.21
25.83%
28.06.21

Could be worthwhile Investment >10% per year
Known brand
Medium risks for its business
overvalued
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€178.02
29.10.19
€190.00
04.11.21
-11.04%
17.06.21

Could be worthwhile Investment >10% per year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€275.40
22.04.20
€320.00
04.11.21
17.79%
17.06.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€69.00
29.03.20
€80.00
04.11.21
-15.28%
17.06.21

Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
positive Cash Flow expected
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€56.50
20.10.20
€60.00
04.11.21
-11.63%
07.06.21

Could be worthwhile Investment >10% per year
Abiomed Inc.

Start price
Target price
Perf. (%)
€266.60
29.04.21
€245.00
29.04.22
-10.43%
07.06.21

Could be worthwhile Investment >10% per year
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.93
05.01.21
-
05.01.22
10.78%
03.06.21

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€416.00
06.02.21
-
06.02.22
7.91%
25.05.21

EBIT growth >5% per year expected
Very low/no dividend yield expected
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€177.80
01.12.19
€300.00
04.11.21
49.94%
29.04.21

Could be worthwhile Investment >10% per year
Teleflex Inc.

Start price
Target price
Perf. (%)
€320.00
21.02.21
-
21.02.22
14.38%
23.04.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
04.08.20
€38.00
04.11.21
0.31%
13.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€136.62
24.03.21
€145.00
24.03.22
-1.26%
09.04.21

Known brand
Future proof or reliable business model
Medium risks for its business
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€62.50
24.02.21
-
24.02.22
1.60%
30.03.21

Probably not worthwhile Investment
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€138.90
05.02.21
-
31.12.21
0.09%
29.03.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€514.00
03.10.20
-
04.11.21
-22.67%
11.03.21

Could be worthwhile Investment >10% per year
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€64.63
25.02.21
€70.00
3.84%
08.03.21

Could be worthwhile Investment >10% per year
Incyte Corp.

Start price
Target price
Perf. (%)
€72.06
20.12.20
-
20.12.21
-7.02%
21.02.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€219.23
21.01.21
€215.00
2.46%
15.02.21

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€134.68
20.01.21
€144.00
0.89%
02.02.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€89.92
30.07.20
€125.00
04.11.21
44.97%
21.01.21

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year